C. Cruickshank

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days

Charlotte Benson, Jeff White, Johann S. de Bono et al. · British Journal of Cancer · 2006 · 259 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)

Steve Nicholson, Emma Hall, S.J. Harland et al. · British Journal of Cancer · 2013 · 135 citations · Full text

Medicine, Oncology, Pharmacology +17

Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer

A. Hunt, Ian Hanson, Alex Dunlop et al. · Clinical and Translational Radiation Oncology · 2020 · 46 citations · Full text

Medicine, Radiation Oncology, Urology +16

Cricothyroidotomy for Long-Term Tracheal Access

Michael J. Sise, R. Shackford, C. Cruickshank et al. · Survey of Anesthesiology · 1985 · 14 citations

Medicine, Surgery, Autopsy Pathology +12

8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group

David P. Dearnaley, Isabel Syndikus, Helen Mossop et al. · European Journal of Cancer · 2015 · 14 citations

Medicine, Oncology, Radiation Oncology +17